Published • loading... • Updated
Harrow (NASDAQ: HROW) closes TYRVAYA deal, adds up to $70 million in milestones
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Harrow (NASDAQ: HROW) closes TYRVAYA deal, adds up to $70 million in milestones
What happened Harrow, Inc. (NASDAQ: HROW) closed its TYRVAYA acquisition from Viatris Inc. and paid $30 million in cash at closing. Harrow got worldwide rights to TYRVAYA except Japan. Viatris kept Japan commercialization rights and will pay Harrow royalties on future net sales there. Harrow funded the closing payment with cash on hand. It may […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
